Goldman Sachs
TMCI icon

Goldman Sachs’s Treace Medical Concepts TMCI Stock Holding History

Goldman Sachs’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.96M Buy
492,116
+104,431
+27% +$287K ﹤0.01% 4698
2026
Q1 		$519K Buy
387,685
+198,833
+105% +$396K ﹤0.01% 5574
2025
Q4 		$463K Sell
188,852
-25,812
-12% -$112K ﹤0.01% 5637
2025
Q3 		$1.44M Sell
214,664
-20,491
-9% -$134K ﹤0.01% 4754
2025
Q2 		$1.38M Sell
235,155
-24,422
-9% -$159K ﹤0.01% 4464
2025
Q1 		$2.18M Sell
259,577
-205,227
-44% -$1.84M ﹤0.01% 4089
2024
Q4 		$3.46M Sell
464,804
-200,348
-30% -$1.34M ﹤0.01% 3812
2024
Q3 		$3.86M Buy
665,152
+416,060
+167% +$2.67M ﹤0.01% 3582
2024
Q2 		$1.66M Buy
249,092
+151,134
+154% +$1.22M ﹤0.01% 4058
2024
Q1 		$1.28M Sell
97,958
-255,564
-72% -$3.41M ﹤0.01% 4181
2023
Q4 		$4.51M Buy
353,522
+231,471
+190% +$2.34M ﹤0.01% 3255
2023
Q3 		$1.6M Buy
122,051
+5,313
+5% +$97.2K ﹤0.01% 3936
2023
Q2 		$2.99M Sell
116,738
-6,963
-6% -$180K ﹤0.01% 3555
2023
Q1 		$3.12M Buy
123,701
+97,115
+365% +$2.28M ﹤0.01% 3495
2022
Q4 		$611K Sell
26,586
-5,642
-18% -$130K ﹤0.01% 4750
2022
Q3 		$711K Buy
32,228
+18,444
+134% +$357K ﹤0.01% 4748
2022
Q2 		$198K Buy
13,784
+45
+0.3% +$758 ﹤0.01% 5645
2022
Q1 		$260K Buy
+13,739
New +$267K ﹤0.01% 5740
2021
Q3 		– Sell
-11,651
Closed -$364K – 6513
2021
Q2 		$364K Buy
+11,651
New +$371K ﹤0.01% 5403

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Goldman Sachs's TMCI Position: Q2 2026 in Review

Goldman Sachs increased its Treace Medical Concepts (TMCI) stake by 27% in Q2 2026, buying an estimated $287K and bringing the position to 492,116 shares worth $1.96M. The position accounts for ﹤0.01% of the portfolio, ranked #4698.

Goldman Sachs first reported a position in TMCI in Q2 2021 and has held it in 19 quarters since. The position peaked at $4.51M in Q4 2023. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Goldman Sachs held 492,116 shares of Treace Medical Concepts worth $1.96M as of Q2 2026.
  • Goldman Sachs bought 104,431 Treace Medical Concepts shares in Q2 2026, an estimated $287K.
  • Treace Medical Concepts made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4698 holding.
  • Goldman Sachs first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 19 quarters since.
  • Goldman Sachs's Treace Medical Concepts position peaked at $4.51M in Q4 2023.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.